ABSTRACT
Each year in the United States, 500 patients are hospitalized for cat-scratch disease, caused by Bartonella henselae infection. We report a case of rare but serious neurologic B. henselae infection. When typical features of cat-scratch disease occur with neurologic findings, Bartonella infection should be suspected and diagnostic testing should be performed.
Subject(s)
Bartonella , Cat-Scratch Disease/complications , Myelitis, Transverse/etiology , Anti-Infective Agents/therapeutic use , Cat-Scratch Disease/cerebrospinal fluid , Cat-Scratch Disease/drug therapy , Cat-Scratch Disease/pathology , Female , Humans , Middle Aged , Myelitis, Transverse/cerebrospinal fluid , Myelitis, Transverse/drug therapySubject(s)
Anti-Infective Agents/therapeutic use , Bartonella henselae , Cat-Scratch Disease/complications , Cat-Scratch Disease/drug therapy , Osteomyelitis/microbiology , Animals , Cat-Scratch Disease/cerebrospinal fluid , Cats , Child , Frontal Bone/diagnostic imaging , Frontal Bone/microbiology , Humans , Lymph Node Excision , Lymphadenopathy/etiology , Lymphadenopathy/surgery , Male , Osteomyelitis/therapyABSTRACT
Bartonella species infection is associated with central nervous system (CNS) disease in some humans and cats but the diagnosis is difficult to confirm with blood or serum test results. In this retrospective study of 100 client-owned cats, serum and cerebral spinal fluid (CSF) were assayed for Bartonella species IgG antibodies and CSF was assayed for Bartonella species DNA. Bartonella species IgG antibodies were detected in serum of 36 cats, Bartonella species C-values>1 (suggesting antibody production by the CNS) were detected in CSF of 11 cats, and B henselae DNA was amplified from the CSF of 10 cats. While the clinical significance of these findings cannot be assessed without a control group, the development of neurological signs in some cats inoculated with B henselae and the results of this study warrant prospective evaluation of the association of Bartonella species with feline CNS disease.